FR2131894A2 - 4-naphthoxy-3-hydroxy-butyramidines as beta-blocking agents - Google Patents

4-naphthoxy-3-hydroxy-butyramidines as beta-blocking agents

Info

Publication number
FR2131894A2
FR2131894A2 FR7111548A FR7111548A FR2131894A2 FR 2131894 A2 FR2131894 A2 FR 2131894A2 FR 7111548 A FR7111548 A FR 7111548A FR 7111548 A FR7111548 A FR 7111548A FR 2131894 A2 FR2131894 A2 FR 2131894A2
Authority
FR
France
Prior art keywords
beta
butyramidines
naphthoxy
hydroxy
blocking agents
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7111548A
Other languages
French (fr)
Other versions
FR2131894B2 (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to FR7111548A priority Critical patent/FR2131894A2/en
Priority to CH735971A priority patent/CH524575A/en
Priority to BE767721A priority patent/BE767721A/en
Priority to GB1755871A priority patent/GB1298525A/en
Priority to NL7107882A priority patent/NL169177C/en
Priority to CA116379A priority patent/CA927385A/en
Priority to LU63418D priority patent/LU63418A1/xx
Priority to DE19712166869 priority patent/DE2166869C3/en
Priority to DE19712132113 priority patent/DE2132113C3/en
Priority to SE829771A priority patent/SE381870B/en
Priority to JP4691971A priority patent/JPS517662B1/ja
Publication of FR2131894A2 publication Critical patent/FR2131894A2/en
Application granted granted Critical
Publication of FR2131894B2 publication Critical patent/FR2131894B2/fr
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D303/00Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02Compounds containing oxirane rings
    • C07D303/12Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/18Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by etherified hydroxyl radicals
    • C07D303/20Ethers with hydroxy compounds containing no oxirane rings
    • C07D303/22Ethers with hydroxy compounds containing no oxirane rings with monohydroxy compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C259/00Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
    • C07C259/12Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. N-hydroxyamidines
    • C07C259/14Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. N-hydroxyamidines having carbon atoms of hydroxamidine groups bound to hydrogen atoms or to acyclic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/20Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D233/22Radicals substituted by oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Title cpds (I) and their salts where A is alpha- or beta-naphthyl; R3 is H or 1-3C alkyl; R2 is H or OH or 1-3C alkyl; and R1 is H or C(:NR1)NR2 is 2-imidazolidinyl or 2-(1,4,5,6-tetrahydropyrimidinyl) and R3 is H are prepd from the butyronitrile by formation of the iminoethe then reaction with HNR2R3. (I, R1=R2=R3=H) with NH2OH or a diamine gives the amino oxime or cyclic amidine. Medicaments are in forms for oral, rectal or perenteral administration.
FR7111548A 1970-06-29 1971-04-01 4-naphthoxy-3-hydroxy-butyramidines as beta-blocking agents Granted FR2131894A2 (en)

Priority Applications (11)

Application Number Priority Date Filing Date Title
FR7111548A FR2131894A2 (en) 1971-04-01 1971-04-01 4-naphthoxy-3-hydroxy-butyramidines as beta-blocking agents
CH735971A CH524575A (en) 1970-06-29 1971-05-19 Process for the preparation of naphthyloxy-butyramidines
BE767721A BE767721A (en) 1970-06-29 1971-05-27 BUTYRAMIDINS
GB1755871A GB1298525A (en) 1970-06-29 1971-05-27 Improvements in or relating to butyramidine compositions
NL7107882A NL169177C (en) 1970-06-29 1971-06-09 METHOD FOR PREPARING OR MANUFACTURING A MEDICINAL PRODUCT, ACTING ON THE CARDIOVASCULAR SYSTEM, AND METHOD FOR PREPARING MEDICINAL ARYLALKYLAMIDINE DERIVATIVES THEREFOR.
CA116379A CA927385A (en) 1970-06-29 1971-06-23 Butyramidine
LU63418D LU63418A1 (en) 1970-06-29 1971-06-25
DE19712166869 DE2166869C3 (en) 1970-06-29 1971-06-28 4-a-Naphthoxy-3-hydroxy-butyramidoxime, process for its preparation and pharmaceutical compositions containing it
DE19712132113 DE2132113C3 (en) 1970-06-29 1971-06-28 Derivatives and analogs of naphthoxybutyramidine and their addition salts with acids, their preparation and pharmaceutical compositions containing them
SE829771A SE381870B (en) 1970-06-29 1971-06-28 PROCEDURE FOR THE PREPARATION OF CERTAIN STATEMENTS THERAPEUTICALLY APPLICABLE BUTYRAMIDINES
JP4691971A JPS517662B1 (en) 1970-06-29 1971-06-29

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7111548A FR2131894A2 (en) 1971-04-01 1971-04-01 4-naphthoxy-3-hydroxy-butyramidines as beta-blocking agents

Publications (2)

Publication Number Publication Date
FR2131894A2 true FR2131894A2 (en) 1972-11-17
FR2131894B2 FR2131894B2 (en) 1974-08-02

Family

ID=9074593

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7111548A Granted FR2131894A2 (en) 1970-06-29 1971-04-01 4-naphthoxy-3-hydroxy-butyramidines as beta-blocking agents

Country Status (1)

Country Link
FR (1) FR2131894A2 (en)

Also Published As

Publication number Publication date
FR2131894B2 (en) 1974-08-02

Similar Documents

Publication Publication Date Title
SE408423B (en) PROCEDURE FOR THE PRODUCTION OF THERAPEUTIC ACTIVE N, N '-DISUBSTITUTED CYCLIC DIAMINES
ES412813A1 (en) 3-Substituted-1,2-benzisoxazoles and pharmaceutically acceptable acid addition salts thereof
FR2131894A2 (en) 4-naphthoxy-3-hydroxy-butyramidines as beta-blocking agents
ES432027A1 (en) Pharmacologically active anilinobenzothiazoles
ES393986A1 (en) 3,4-dihydroxy-benzylalcohol amino derivatives
FR2134218A1 (en) Phloroglucinol aminoketones - vasodilators and antispasmodics
FR2275455A1 (en) D-Hydroxyalkyl desoxyvincaminates - by hydrogenation of 2-oxoalkyl desoxyvincaminates and the corresp. apovincaminates (NO190176)
FR2138488A1 (en) 1-(5-indanyl)-omega-aminoalkanes - with tranquillizing activity
ES372209A1 (en) Alpha-{8 (phenyl sulfinyl)methyl{9 -alpha-phenyl derivatives of pyridinemethanols
FR2148369A1 (en) Phloroglucinol carbates - as beta-blocking agents
Schumacher et al. The influence of urea on protein synthesis of stimulated lymphocytes
FR2129914A2 (en) Sulphonic acid salts of aliphatic diamines - with antiviral activity
FR2231656A1 (en) Substd phenoxy acetates - as water sol herbicides
ES419044A1 (en) New derivatives of 1,4-benzodioxan, the preparation and the use thereof
FR2137022A1 (en) 4-(alpha-naphthoxy)-butyramidoxime - useful as an anti -arrythmic agent
FR2210388A1 (en) 4-Phenoxy-3-hydroxy-butyramidines - as agents for treating cardiac rhythm disorders
PH9783A (en) Process for the preparation of n-(n',n'-dilower-alkylaminoloweralkylene)-4-amino-2,5-disubstituted benzamides
FR2152361A1 (en) Bis (aminoalkylsulfamoyl) anthraquinones - useful as antiviral agents
GB1270877A (en) Halogenated silicon-containing cyclic acetals and a process for their preparation
FR2201885A1 (en) 4-Aryl carbonyl methyl pyrimidine oxime carbamates - prepd. by treatment of the oxime with an isocyanate, used as sedatives, analgesics, vasodilators, diuretics
GB1390650A (en) Oxazines and thiazines
FR2157837A1 (en) Substd phenyl - alkanaldehyde - thiosemicarbazones - contraceptives
FR2085645A1 (en) 1-phenyl-2,3-benzodiazepin-4-ones - as tranquillizers
FR2188601A5 (en) 2-methoxy-5-alkylsulphonylbenzamides - pharmaceuticals
GB1289956A (en)

Legal Events

Date Code Title Description
TP Transmission of property